The effect of treatment with bisoprolol-first versus enalapril-first on cardiac structure and function in heart failure

International Journal of Cardiology

Volumn 144, Issue 1, 2010, Pages 59-63

  Van De Ven, Louis L M ^a   Van Veldhuisen, Dirk J ^b   Goulder, Michael ^c   Zilahi, Zsolt ^d   Meyer, Wilfried R ^e   Willenheimer, Ronnie ^f  

^a Clinquest Europe   (Netherlands)

^b UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^c Nottingham Clinical Research Limited   (United Kingdom)

^d Szabolcs Country Hospital   (Hungary)

^e MERCK KGAA   (Germany)

^f LUND UNIVERSITY   (Sweden)

Author keywords

Adrenergic beta antagonists; Angiotensin converting enzyme inhibitors; Cardiac remodelling; Drugs; Heart failure

Indexed keywords

BISOPROLOL; ENALAPRIL;

ADULT; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; ECHOCARDIOGRAPHY; FEMALE; HEART FAILURE; HEART FUNCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART LEFT VENTRICLE ENDDIASTOLIC VOLUME; HUMAN; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL;

ADRENERGIC BETA-1 RECEPTOR ANTAGONISTS; AGED; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; BISOPROLOL; BLOOD PRESSURE; DOSE-RESPONSE RELATIONSHIP, DRUG; ECHOCARDIOGRAPHY; ENALAPRIL; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE; HEART RATE; HUMANS; MALE; PROSPECTIVE STUDIES; STROKE VOLUME; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT; VENTRICULAR REMODELING;

EID: 77957863834     PISSN: 01675273     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijcard.2009.04.040     Document Type: Article

References (29)

1. R.B. Singh, F. Demeester, L. Juneja, Y. Michirova, and D. Pella New risk factors of heart failure Eur Heart J 28 2007 1038 1039
2. M. Fuchs, and H. Drexler Pharmacotherapy of chronic heart failure: current status and future aspects Eur Heart J 4 Suppl I 2002 I81 I87
3. W.P. Klinke, L.G. Christie, W.W. Nichols, M.E. Ray, R.C. Curry, and C.R. Pepine CJ Cont Use of catheter-tip velocity pressure transducer to evaluate the left ventricular function. In man effects of intravenous propranolol Circulation 61 1980 946 954
4. R. Willenheimer, D.J. van Veldhuisen, and B. Silke on behalf of the CIBIS-III investigators. Effects on survival and hospitalization of initiating treatment for chronic heart failure with bisoprolol followed by enalapril as compared with the opposite sequence. Results of the randomized cardiac insufficiency bisoprolol study (CIBIS) III trial Circulation 112 2005 2426 2435
5. R. Willenheimer, E. Erdmann, and F. Follath on behalf of the CIBIS-III investigators. Comparison of treatment initiation with bisoprolol versus enalapril in chronic heart failure patients: Rationale and Design of CIBIS-III Eur J Heart Fail 6 2004 493 500
6. D.R. Murray, and J. Dugan Overview of recent clinical trials in heart failure: what is the current standard of care? Cardiol Rev 8 2000 340 347
7. J. Abdulla, S. Barlera, and R. Latini A systemic review: effects of angiotensin converting enzyme inhibition on left ventricular volumes and ejection fraction in patients with a myocardial infarction and in patients with left ventricular dysfunction Eur J Heart Fail 9 2007 129 135
8. K. Sliwa, G.R. Norton, and N. Kone Impact of initiating carvedilol before angiotensine inhibitor therapy on cardiac function in newly diagnosed heart failure J Am Coll Cardiol 44 2004 1825 1830
9. S.J. Pocock, D. Wang, and M.A. Pfeffer Predictors or mortality and morbidity in patients with chronic heart failure Eur Heart J 27 2006 65 75
10. L. Hansson, T. Hedner, and B. Dahlöf Prospective Randomized Open Blinded End-point (PROBE) Study. A novel design for intervention trials Blood Pressure 1 1992 113 119
11. N. Reinschek, J. Wilson, and M.J. Sutton Non invasive determination of left ventricular enddiastolic stress. Validation of the method and initial application Circulation 65 1982 99 108
12. Kurt J.G. Schmaizl, and Oliver Ormerod Ultrasound in cardiology Blackwell Sci 1994 672 673 0-86542-802-6
13. G.S. Francis, C. Benedict, and D.E. Johnston Comparison of neuroendocrine activation in patients with left ventricular dysfunction with and without congestive heart failure: a sub study of the Studies Of Left Ventricular Dysfunction (SOLVD) Circulation 82 1990 1724 1729
14. B. Greenberg, M.A. Quinones, and C. Koilpillai Effects of long-term enalapril therapy on cardiac structure and function in patients with left ventricular dysfunction: results of the SOLVD echocardiographic sub study Circulation 91 1995 2573 2581
15. The task force for the diagnosis and treatment of acute and chronic heart failure 2008 of the European society of cardiology. Developed in collaboration with the heart failure association of the ESC (HFA) and endorsed by the European society of intensive care medicine (ESICM). ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008. EHJ 2008; 29, 2388-2442.
16. S.A. Hunt, W.T. Abraham, and M.H. Chin American College of Cardiology/American Heart Association Task Force on Practice Guidelines Writing Committee to update the 2001 Guidelines for the Evaluation and Management of Heart Failure Circulation 108 2005 1825 1852
17. S.S. Gottlieb, M.L. Fischer, and J. Kjekshus Tolerability of beta-blocker initiation and titration in the Metoprolol CR/XL Randomised Intervention Trial in Congestive Heart Failure (MERIT-HF) Circulation 105 2002 1182 1188
18. W.J. Remme, G. Riegger, and P. Hildebrandt The benefits of early combination treatment of carvedilol and an ACE-inhibitor in mild heart failure and left ventricular systolic dysfunction. The carvedilol and ACE-inhibitor remodelling mild heart failure evaluation trial (CARMEN) Cardiovasc Drugs Ther 18 2004 57 66
19. N. Sharpe, and R.N. Doughty Left ventricular remodelling and improved Long-term outcomes in chronic heart failure Eur Heart J 19 suppl B 1998 B36 B39
20. B.M. Massie, B.L. Kramer, and N. Topic Acute and long term effects of captopril on left and right ventricular volumes and function in chronic heart failure Am Heart J 104 1982 1197 1203
21. D. Dobre, D.J. van Velthuizen, M.A. Goulder, H. Krum, and R. Willenheimer Clinical effects of initial 6 months monotherapy with bisoprolol versus Enalapril in the treatment of patients with mild to moderate chronoc heart failure. Data from the CIBIS III trial Cardiovasc Drugs Ther 22 2008 399 405
22. R.H. Doughty, G.A. Whalley, and G. Gamble Left ventricular remodelling with carvedilol in patients with congestive heart failure due to ischemic heart disease: Australia-New Zealand Heart Failure Research Collaborative Group J Am Coll Cardiol 29 1997 1060 1066
23. J.N. Cohn, R. Ferrari, and N. Sharpe on behalf of the international forum on cardiac remodeling. Cardiac remodelling Concept and clinical implications: a consensus paper from an international forum on cardiac remodelling JACC 35 2000 569 582
24. G.V. Packer M, Antalopoulos, and J.A. Berlin Comparative effects of carvedilol and metoprolol on left ventricular ejection fraction in heart failure: results of a meta analysis Am Heart J 141 2001 899 907
25. F. Waagstein Betablockers in congestive heart failure D.J. van Veldhuisen, B. Pitt, Chronoc Heart Failure 2002 Benecke N.I. Amsterdam
26. P. Lechat, S. Escolano, and J.L. Golmard Prognostic value of bisoprolol induced hemodynamic effects in heart failure Turing the cardiac insufficiency bisoprolol Study (CIBIS) Circulation 96 1997 2197 2205
27. P. de Grootte, P. Delour, and N. Lamblin Effects of bisoprolol in patients with stable congestive heart failure Ann Cardiologie Angeologie 53 2004 167 170
28. F. Waagstein Betablockers in congestive heart failure D.J. van Veldhuisen, B. Pitt, Chronoc Heart Failure 2002 Benecke N.I. Amsterdam
29. A.J. Coats Ethical authorship and publishing Int J Cardiol 131 2009 149 150